Basal Ganglia Diseases  >>  eszopiclone  >>  Phase 3
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
eszopiclone / Generic mfg.
NCT00324896: Treatment of Insomnia in Patients With Parkinson's Disease: A Multi-site, Placebo-controlled Study of Eszopiclone

Completed
3
30
US
eszopiclone, Lunesta 2 - 3 mg q HS, placebo
University of Medicine and Dentistry of New Jersey, Sunovion
Parkinson's Disease, Insomnia
06/09
06/09

Download Options